Welcome to our dedicated page for Vystar news (Ticker: VYST), a resource for investors and traders seeking the latest updates and insights on Vystar stock.
Vystar Corporation (OTCQB: VYST) generates news across several distinct business lines, including Vytex natural rubber latex materials, RxAir UV-C air purification systems, Fluid Energy Conversion technologies, and tokenization of collectibles and digital assets through GoPaid.com and related initiatives. News coverage often reflects product developments, legal milestones, and strategic partnerships described by the company.
Recent announcements have included a binding Letter of Intent to acquire a minority equity stake in GoPaid.com LLC and participate in its proprietary cryptocurrency, along with plans to collaborate with Capital R3alm on R3alm Collectibles and R3alm Oracle platforms focused on tokenized memorabilia and decentralized oracle services. Vystar has also issued updates on Vytex-based mattresses and toppers, enhancements to RxAir air purifiers such as extended-life UV-C bulb cartridges, and progress on integrating Fluid Energy Conversion’s Hughes Reactor technology into next-generation air purification prototypes.
Investors and observers following VYST news can expect disclosures on product launches and relaunches, technology refinements in air purification and fluid energy, developments in Vytex applications, and corporate or legal updates such as court decisions involving convertible note litigation. Because Vystar operates at the intersection of materials science, health-related air quality products, energy-focused fluidics, and Web3 collectibles tokenization, its news flow spans multiple sectors and themes.
This page aggregates Vystar-related press releases and third-party coverage in one place, making it easier to review the company’s reported activities and announcements over time.
Vystar (OTCQB: VYST) and Capital Realm launched R3alm.com on April 21, 2026, and announced a proposed strategic transaction where Vystar would acquire a 50% interest in R3alm, Inc.
The platform targets tokenization, AI-driven compliance, private markets and a proposed R3EQ equity token, citing third-party estimates that the tokenized asset market could reach $2–$5 trillion by 2030.
Vystar (OTCQB: VYST) entered a binding letter of intent to acquire a 50% interest in R3alm, a compliance-focused AI and Web3 financial ecosystem. Consideration includes approximately 8,500 shares of Vystar Series B preferred stock and an R3EQ token allocation.
R3alm comprises 22 planned modules spanning tokenized assets, governance, trading, treasury, identity, analytics and an AI financial intelligence layer. Closing is anticipated in less than 60 days, subject to definitive agreements, due diligence and board approvals. Management cites a market opportunity of $2–5 trillion near term, up to $10 trillion longer term.
Vystar (OTCQB: VYST) launches a 14-day free memorabilia sweepstakes beginning February 18, 2026, driven by a social media push on X to promote the GoPaid collectibles ecosystem and tokenization initiatives.
Daily prizes ($25–$250 ARV) awarded Monday–Friday; winners contacted via X @JRC_Stocks. Vystar announced a partnership with GoPaid and Capital R3alm to pursue tokenized collectibles, a R3alm marketplace targeted for Q2 2026, and an oracle network for valuations and provenance.
Vystar (OTCQB: VYST) acquired 100% of Fluid Energy Conversion (FEC) assets, including the patented Hughes Reactor, and says a water filtration enhancement device is in final prototype testing to improve dialysis efficiency. Vystar expects FEC tech to reduce RxAir purifier size and cost, boost pathogen kill rates, and enable eco-friendly product initiatives across water, metering, and medical uses.
The company cites an estimated 1.7 billion gallons saved for one dialysis company and anticipates completing final testing in the current quarter.
Vystar (OTCQB: VYST) submitted a binding Letter of Intent dated Dec 4, 2025 to acquire a minority equity stake in GoPaid.com LLC and a percentage of GoPaid’s proprietary cryptocurrency or the lesser of a $10 million valuation.
The initial purchase price is 1,000 shares of Series C preferred common stock, with options to acquire up to an additional 10% equity and 3% cryptocurrency/b over two years, exercisable semi-annually. Target closing is on or before . Vystar committed to help raise $250,000 and to partner with Capital R3alm to launch R3alm Oracle and a Q2 2026 white-label R3alm Collectibles marketplace.
Vystar (OTCQB: VYST) announced a court victory dated Dec. 22, 2025 after four years of litigation against EMA Financial that resulted in dismissal of EMA’s suit seeking damages “in excess of $4,226,187.”
The U.S. Court of Appeals for the Second Circuit denied EMA’s appeal and the court awarded Vystar $497,439.58 in legal fees and costs. Vystar thanked its litigation and corporate counsel and named outside accountants who supported the case.
Vystar (OTCQB: VYST) announced that Internet and Incubator Stock Review initiated coverage on October 24, 2025, citing Vystar’s portfolio of four start-ups and development support for management, structuring and marketing.
Highlights include Vytex latex alternatives for medical and consumer uses, FDA-cleared RxAir 400 air purifier covering up to 800 sq ft, energy technologies at FEC, and a planned GoPaid.com tokenization portal with a full launch expected in Q4 2025 and a BETA imminent. The research firm emphasized tokenization’s potential to expand access to the collectibles and fine art market.
Vystar (OTCQB: VYST) announced on October 17, 2025 that the Vytex® Cloud Bed-in-a-Box collection is available for sale exclusively at www.vytex.com.
The line features 100% natural deproteinized Vytex latex in three support levels (firm, plush, super plush), six sizes, a 9-inch thickness, a quilted organic cotton over Joma wool cover, a free topper, and optional pillows and toppers. Product claims include 99.8% protein removal, a 90% stronger bond for durability, full biodegradability, and an expected useful life of 20+ years. Bed-in-a-Box industry sales are noted at nearly 35% of mattress sales.
Vystar Corporation (OTCQB: VYST) announced the relaunch of its Vytex® Cloud Bed-in-a-Box mattress collection, targeting the rapidly growing $30 billion mattress industry. The product line features 100% natural latex mattresses available in three support levels and six sizes, with bed-in-a-box sales now representing nearly 30% of all mattress sales.
The 9-inch thick mattresses will be available from October 1st, 2025, featuring a quilted organic cotton over Joma™ wool cover. Key product features include 20+ years of durability, natural antimicrobial properties, and Vystar's multi-patented deproteinization technology that removes 99.8% of allergy-causing proteins. The company offers a 100-day free trial and a 10-year warranty against manufacturing defects.
Vystar Corporation (OTCQB: VYST) has introduced an enhanced version of its RxAir400 UV-C light air purification system with new features. The key innovation is the Extended Life 18,000 Hour RxAir400 UV-C Pro bulb replacement cartridge, doubling the lifespan of the standard 9,000-hour cartridge.
The company has also added an ergonomic integrated handle and wall mount bracket options for improved portability. The RxAir400, a smaller version of the FDA-certified Class II medical device Rx3000, is proven to inactivate >99.9% of airborne pathogens including coronavirus strains. With 25,000 RxAir units operating worldwide, the market demands approximately 40,000 cartridge changes annually. The new extended life cartridge is priced at $375, offering cost savings compared to the standard $199 cartridge.